Page last updated: 2024-08-17

aspartic acid and Blood Clot

aspartic acid has been researched along with Blood Clot in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Chen, R; Guo, Y; Huang, Y; Jiang, J; Li, Y; Ren, J; Zhao, Q; Zhou, J1
Adeli, K; Adili, R; Carrim, N; Chen, P; Chen, Y; Connelly, PW; Cyr, T; Davidson, WS; Freedman, J; Fu, W; Gallant, RC; Jackson, SP; Jin, JW; Ju, L; Ke, P; Lee, JE; Lei, X; Liu, G; Marchese, P; Neves, MAD; Ni, H; Rand, ML; Ruggeri, ZM; She, YM; Song, J; Spring, CM; Tso, P; Wang, Y; Xu, M; Xu, XR; Yang, H; Yang, Y; Yu, SY; Zhang, D; Zhang, H; Zhu, C; Zhu, G1
Brennan, SO; Chitlur, M1
Luu, NC; McKean, R; Ridge, DP; Robinson, S; Zhao, R1
Gould, J; Hegener, HH; Ridker, PM; Zee, RY1
Chen, Y; Cui, G; Lee, KH; Morris-Natschke, S; Peng, S; Qian, K; Wang, C; Zhao, M1
Ichinose, A; Mlyata, T; Saito, T; Sakata, T; Tsutsumi, S1
Collins, WE; Cooper, SL; Mosher, DF; Tomasini, BR1
Murray, M; Smith, GF1

Other Studies

9 other study(ies) available for aspartic acid and Blood Clot

ArticleYear
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
    Advanced healthcare materials, 2022, Volume: 11, Issue:19

    Topics: Animals; Arginine; Aspartic Acid; Chitosan; Fibrinogen; Fibrinolytic Agents; Glycine; Hemorrhage; Hemostatics; Mice; Oligopeptides; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator

2022
Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis.
    Nature communications, 2018, 09-06, Volume: 9, Issue:1

    Topics: Adult; Animals; Apolipoproteins A; Aspartic Acid; Binding Sites; Circadian Rhythm; Disease Models, Animal; Humans; Mice, Inbred C57BL; Mice, Transgenic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postprandial Period; Recombinant Proteins; Thrombosis

2018
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:6

    Topics: Afibrinogenemia; Aspartic Acid; Binding Sites; Chromatography, High Pressure Liquid; Dimerization; Fibrinogen; Gene Deletion; Genetic Variation; Histidine; Humans; Infant; Male; Mutation; Phenotype; Sequence Analysis, DNA; Thrombosis; Tyrosine

2013
Mass spectrometric differentiation of alpha- and beta-aspartic acid in a pseudo-tetrapeptide thrombosis inhibitor and its isomer.
    European journal of mass spectrometry (Chichester, England), 2004, Volume: 10, Issue:2

    Topics: Aspartic Acid; Isoaspartic Acid; Isomerism; Kinetics; Molecular Structure; Oligopeptides; Spectrometry, Mass, Electrospray Ionization; Thrombosis

2004
Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis.
    Stroke, 2005, Volume: 36, Issue:1

    Topics: Amino Acid Substitution; Aspartic Acid; Case-Control Studies; Genetic Predisposition to Disease; Glycine; Humans; Incidence; Membrane Glycoproteins; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies; Receptors, Cell Surface; Stroke; Thrombosis; Toll-Like Receptor 4; Toll-Like Receptors

2005
Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu.
    Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11

    Topics: Animals; Arginine; Aspartic Acid; Aspirin; Circular Dichroism; Dose-Response Relationship, Drug; Fibrinolytic Agents; Glutamic Acid; Nanostructures; Oligopeptides; Particle Size; Platelet Aggregation Inhibitors; Rats; Thrombosis

2008
Genetic diagnosis of dysplasminogenemia: detection of an Ala601-Thr mutation in 118 out of 125 families and identification of a new Asp676-Asn mutation.
    Thrombosis and haemostasis, 1996, Volume: 76, Issue:2

    Topics: Adult; Alanine; Asparagine; Aspartic Acid; Female; Genetic Testing; Humans; Male; Mutation; Phenylalanine; Plasminogen; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Structure-Activity Relationship; Threonine; Thrombosis

1996
A preliminary comparison of the thrombogenic activity of vitronectin and other RGD-containing proteins when bound to surfaces.
    Annals of the New York Academy of Sciences, 1987, Volume: 516

    Topics: Adsorption; Animals; Arginine; Aspartic Acid; Biocompatible Materials; Blood Proteins; Dogs; Glycine; Glycoproteins; Humans; Polymers; Surface Properties; Thrombosis; Vitronectin

1987
Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
    Archives of pathology, 1970, Volume: 89, Issue:3

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Binding Sites; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Edetic Acid; Fibrin; Fibrinogen; Glycine; Humans; Immunoelectrophoresis; Models, Biological; Thrombin; Thrombosis; Tyrosine

1970